Sfoglia per Autore MALAGUARNERA, ROBERTA
p73 tumor suppressor activity is impaired in thyroid cancer
2003-01-01 Vella, V; Frasca, F; Mazzon, E; Aloisi, A; Mandarino, A; Malaguarnera, R; Vigneri, R
Ruolo di p73 nella progressione tumorale tiroidea
2003-01-01 Frasca, F; Vella, V; Mandarino, A; Vigneri, P; Malaguarnera, R; Vigneri, R
c-ABL tyrosine kinase inhibits insulin induced proliferation and migration in HepG2 cancer cells: role of focal adhesion kinase
2003-01-01 Frasca, F; Mandarino, A; Pandini, G; Malaguarnera, R; Vella, V; Vigneri, R
Espressione e funzioni di p63 nel carcinoma tiroideo
2003-01-01 Malaguarnera, R; Mandarino, A; Vella, V; Vigneri, R; Frasca, F
TAp63 antagonizes p53 oncosuppressor function in thyroid cancer cells
2004-01-01 Frasca, F; Mandarino, A; Malaguarnera, R; Vella, V; Aloisi, A; Cassarino, F; Vigneri, R
Involvement of c-ABL tyrosine kinase in insulin and IGF-I signaling
2005-01-01 Frasca, F; Mandarino, A; Malaguarnera, R; Belfiore, A; Pandini, G; Vigneri, R
Carcinoma anaplastico della tiroide: p53 e p73 hanno un effetto sinergico nell'indurre apoptosi
2005-01-01 Malaguarnera, R; Mineo, R; Pandini, G; Vigneri, R; Frasca, F
Cooperation of p73 and p53 in anaplastic thyroid cancer cell apoptosis
2005-01-01 Malaguarnera, R; Mineo, R; Pandini, G; Vigneri, R; Frasca, F
HMGA1 inibisce le funzioni delle proteine appartenenti alla famiglia di p53 in cellule di carcinoma tiroideo
2005-01-01 Frasca, F; Malaguarnera, R; Manfioletti, G; Vigneri, R
The p53-homologue p63 may promote thyroid cancer progression
2005-01-01 Malaguarnera, R; Mandarino, A; Mazzon, E; Vella, V; Gangemi, P; Vancheri, C; Vigneri, P; Aloisi, A; Vigneri, R; Frasca, F
HMGA1 inhibits the function of p53 family members in thyroid cancer cells
2006-01-01 Frasca, F; Rustighi, A; Malaguarnera, R; Altamura, S; Vigneri, P; Del Sal, G; Ginacotti, V; Pezzino, V; Vigneri, R.; and Manfioletti, G
TAp73? Increases p53 tumor suppressor activity in thyroid cancer cells via inhibition of Mdm2-mediated degradation
2007-01-01 Frasca, F; Messina, Rl; Malaguarnera, R; Vella, V; Sanfilippo, M; Pezzino, V; Vigneri, R
mTOR is a therapeutic target in thyroid cancer: determinants of rapamycin response in human thyroid cancer cell lines
2007-01-01 Malaguarnera, R; Baumgartner, J; Knauf, Ja; Benezra, M; Fagin, Ja
mTOR signling is required for DNA synthesis induced by either RET/PTC, oncogenic RAS or BRAF in rat thyroid PCCL3 cells
2007-01-01 Malaguarnera, R; Ouyang, B; Knauf, Ja; Fagin, Ja
The RET Kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells
2007-01-01 Akeno-Stuart, N; Croyle, M; Knauf, Ja; Malaguarnera, R; Vitagliano, D; Santoro, M; Stephan, C; Grosios, K; Wartmann, M; Cozens, R; Caravatti, G; Fabbro, D; Lane, Ha; Fagin, Ja
p53 family proteins in thyroid cancer
2007-01-01 Malaguarnera, R; Vella, V; Vigneri, R; Frasca, F
Role of c-ABL in directing metabolic versus mitogenic effects in insulin receptor signaling
2007-01-01 Frasca, F; Pandini, G; Malaguarnera, R; Mandarino, A; Messina, Rl; Sciacca, L; Belfiore, A; Vigneri, R
Modeling BRAF-induced thyroid tumorigenesis in mice:evidence for a causal role of oncogenic BRAF activation on loss of thyroid differentiated function in vivo
2008-01-01 Malaguarnera, R; Chakravarty, D; Franco, A; Knauf, J; Marais, R; Pritchard, C; Ghossein, R; Liao, X-H; Refetoff, S; FAGIN J., A
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation
2008-01-01 Malaguarnera, R; Vella, V; Pandini, G; Pezzino, V; Vigneri, R; Frasca, F
BRAFV600E mutation is associated with preferential sensitivity to MEK inhibition in thyroid cancer cell lines
2008-01-01 Leboeuf, R; Baumgartner, Je; Benezra, M; Malaguarnera, R; Solit, D; Pratilas, Ca; Rosen, N; Knauf, Ja; Fagin, Ja
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
p73 tumor suppressor activity is impaired in thyroid cancer | 1-gen-2003 | Vella, V; Frasca, F; Mazzon, E; Aloisi, A; Mandarino, A; Malaguarnera, R; Vigneri, R | |
Ruolo di p73 nella progressione tumorale tiroidea | 1-gen-2003 | Frasca, F; Vella, V; Mandarino, A; Vigneri, P; Malaguarnera, R; Vigneri, R | |
c-ABL tyrosine kinase inhibits insulin induced proliferation and migration in HepG2 cancer cells: role of focal adhesion kinase | 1-gen-2003 | Frasca, F; Mandarino, A; Pandini, G; Malaguarnera, R; Vella, V; Vigneri, R | |
Espressione e funzioni di p63 nel carcinoma tiroideo | 1-gen-2003 | Malaguarnera, R; Mandarino, A; Vella, V; Vigneri, R; Frasca, F | |
TAp63 antagonizes p53 oncosuppressor function in thyroid cancer cells | 1-gen-2004 | Frasca, F; Mandarino, A; Malaguarnera, R; Vella, V; Aloisi, A; Cassarino, F; Vigneri, R | |
Involvement of c-ABL tyrosine kinase in insulin and IGF-I signaling | 1-gen-2005 | Frasca, F; Mandarino, A; Malaguarnera, R; Belfiore, A; Pandini, G; Vigneri, R | |
Carcinoma anaplastico della tiroide: p53 e p73 hanno un effetto sinergico nell'indurre apoptosi | 1-gen-2005 | Malaguarnera, R; Mineo, R; Pandini, G; Vigneri, R; Frasca, F | |
Cooperation of p73 and p53 in anaplastic thyroid cancer cell apoptosis | 1-gen-2005 | Malaguarnera, R; Mineo, R; Pandini, G; Vigneri, R; Frasca, F | |
HMGA1 inibisce le funzioni delle proteine appartenenti alla famiglia di p53 in cellule di carcinoma tiroideo | 1-gen-2005 | Frasca, F; Malaguarnera, R; Manfioletti, G; Vigneri, R | |
The p53-homologue p63 may promote thyroid cancer progression | 1-gen-2005 | Malaguarnera, R; Mandarino, A; Mazzon, E; Vella, V; Gangemi, P; Vancheri, C; Vigneri, P; Aloisi, A; Vigneri, R; Frasca, F | |
HMGA1 inhibits the function of p53 family members in thyroid cancer cells | 1-gen-2006 | Frasca, F; Rustighi, A; Malaguarnera, R; Altamura, S; Vigneri, P; Del Sal, G; Ginacotti, V; Pezzino, V; Vigneri, R.; and Manfioletti, G | |
TAp73? Increases p53 tumor suppressor activity in thyroid cancer cells via inhibition of Mdm2-mediated degradation | 1-gen-2007 | Frasca, F; Messina, Rl; Malaguarnera, R; Vella, V; Sanfilippo, M; Pezzino, V; Vigneri, R | |
mTOR is a therapeutic target in thyroid cancer: determinants of rapamycin response in human thyroid cancer cell lines | 1-gen-2007 | Malaguarnera, R; Baumgartner, J; Knauf, Ja; Benezra, M; Fagin, Ja | |
mTOR signling is required for DNA synthesis induced by either RET/PTC, oncogenic RAS or BRAF in rat thyroid PCCL3 cells | 1-gen-2007 | Malaguarnera, R; Ouyang, B; Knauf, Ja; Fagin, Ja | |
The RET Kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells | 1-gen-2007 | Akeno-Stuart, N; Croyle, M; Knauf, Ja; Malaguarnera, R; Vitagliano, D; Santoro, M; Stephan, C; Grosios, K; Wartmann, M; Cozens, R; Caravatti, G; Fabbro, D; Lane, Ha; Fagin, Ja | |
p53 family proteins in thyroid cancer | 1-gen-2007 | Malaguarnera, R; Vella, V; Vigneri, R; Frasca, F | |
Role of c-ABL in directing metabolic versus mitogenic effects in insulin receptor signaling | 1-gen-2007 | Frasca, F; Pandini, G; Malaguarnera, R; Mandarino, A; Messina, Rl; Sciacca, L; Belfiore, A; Vigneri, R | |
Modeling BRAF-induced thyroid tumorigenesis in mice:evidence for a causal role of oncogenic BRAF activation on loss of thyroid differentiated function in vivo | 1-gen-2008 | Malaguarnera, R; Chakravarty, D; Franco, A; Knauf, J; Marais, R; Pritchard, C; Ghossein, R; Liao, X-H; Refetoff, S; FAGIN J., A | |
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation | 1-gen-2008 | Malaguarnera, R; Vella, V; Pandini, G; Pezzino, V; Vigneri, R; Frasca, F | |
BRAFV600E mutation is associated with preferential sensitivity to MEK inhibition in thyroid cancer cell lines | 1-gen-2008 | Leboeuf, R; Baumgartner, Je; Benezra, M; Malaguarnera, R; Solit, D; Pratilas, Ca; Rosen, N; Knauf, Ja; Fagin, Ja |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile